Gen9 gets $25M in equity funding for DNA synthesis

Gen9, a Cambridge-based synthetic biology co-founded in 2009 by Harvard professor George Church, has filed for the receipt of $25 million in equity...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.